Skip to main content
Download PDF
- Main
CD4:CD8 ratio and CD8+ cell count for prognosticating mortality in HIV-infected patients on antiretroviral therapy
Published Web Location
https://doi.org/10.21037/jlpm.2018.01.10Abstract
In people living with HIV (PLWH), immune compromise is largely due to a decrease in CD4 + T-lymphocyte (CD4) cells, resulting in increased rates of human immunodeficiency virus (HIV)-associated morbidity and mortality as CD4 + cell count declines. Previously, it was common to defer initiation of antiretroviral therapy (ART) in asymptomatic PLWH until their CD4 + cell count declined below a certain threshold, which has changed throughout the years based on updated guidelines, increasing access to ART, and lower drug prices.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.